Instruction for use: Tagista

Dosage form: tablets

Active substance: Betahistine*

ATX

N07CA01 Betahistine

Pharmacological group:

Histamine preparation [Angioprotectors and microcirculation correctors]

The nosological classification (ICD-10)

H81.0 Meniere's disease: Meniere's syndrome/ disease; Meniere's disease; Meniere's syndrome; Labyrinth dropsy; endolymphatic hydrops

H81.4 Vertigo of central origin: Vertigo labyrinthine origin; vestibular vertigo; Vertigo of vascular origin

H83.3 Noise in the inner ear: Noise in the ears; Idiopathic tinnitus

H91 Other hearing loss: Age-related vascular hearing loss; Age-related vascular drop in hearing; Age-related hearing impairment; Idiopathic hearing loss; Decreased acuity of hearing; Hearing loss; Deteriorating hearing of vascular or toxic origin; Perceptual hearing loss

R42 Dizziness and disturbance stability: vertigo; Dizziness; Dizziness and nausea during travel on transport; disorders of balance; vestibular disorders; disequilibrium; Ischemic disorders of hearing and balance

Composition

Tablets - 1 table.

active substance: Betahistine dihydrochloride in terms of 100% dry matter 8 mg; 16 mg; 24 mg

Auxiliary substances: MCC - 54.75 / 109.5 / 164.25 mg; Povidone (Kollidon 25) - 9/18/27 mg; Potato starch - 20/40/60 mg; Citric acid - 2/4/6 mg; Silicon dioxide colloid (aerosil) - 3/6/9 mg; Talc - 2,8 / 5,6 / 8,4 mg; Magnesium stearate - 0.45 / 0.9 / 1.35 mg

Pharmachologic effect

Mode action - improving microcirculation, histamine-like.

Dosing and Administration

Inside, with food.

Tablets 8 mg: 1-2 tablets. 3 times a day.

Tablets 16 mg: 1 / 2-1 table. 3 times a day.

Tablets 24 mg: 1 table. 2 times a day.

Improvement is usually noted already at the beginning of therapy, a stable therapeutic effect occurs after 2 weeks of treatment and may increase over several months of treatment. Treatment is long. The duration of treatment is determined individually.

Release form

Tablets, 8 mg, 16 mg and 24 mg.

When manufactured at OOO Makyz-Pharma, Russia

In the outline of the cell packaging of PVC film and aluminum foil, 10 or 30 pcs. 3 or 5 contour cell packs of 10 tables, 1, 2 or 3 contour squares per 30 tab. In a pack of cardboard.

When produced at OOO Hemofarm, Russia

In the outline of the cell packaging of a PVC film and aluminum foil or in a planar cell pack of aluminum foil, 10 or 30 pcs. 3 or 5 contour cell packs of 10 tables, 1, 2 or 3 contour squares per 30 tab. In a pack of cardboard.

Conditions of leave from pharmacies

On prescription.

Storage conditions of the drug Tagista

In a dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life of the drug Tagista

3 years.

Do not use after the expiry date printed on the package.